305 related articles for article (PubMed ID: 11000002)
1. BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.
Babu YS; Chand P; Bantia S; Kotian P; Dehghani A; El-Kattan Y; Lin TH; Hutchison TL; Elliott AJ; Parker CD; Ananth SL; Horn LL; Laver GW; Montgomery JA
J Med Chem; 2000 Sep; 43(19):3482-6. PubMed ID: 11000002
[No Abstract] [Full Text] [Related]
2. Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity.
Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin TH; Hutchison TL; Babu YS; Bantia S; Elliott AJ; Montgomery JA
J Med Chem; 2001 Dec; 44(25):4379-92. PubMed ID: 11728184
[TBL] [Abstract][Full Text] [Related]
3. RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza.
Young D; Fowler C; Bush K
Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1905-13. PubMed ID: 11779391
[TBL] [Abstract][Full Text] [Related]
4. The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase.
Bromba CM; Mason JW; Brant MG; Chan T; Lunke MD; Petric M; Boulanger MJ; Wulff JE
Bioorg Med Chem Lett; 2011 Dec; 21(23):7137-41. PubMed ID: 22001088
[TBL] [Abstract][Full Text] [Related]
5. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
Smith PW; Sollis SL; Howes PD; Cherry PC; Starkey ID; Cobley KN; Weston H; Scicinski J; Merritt A; Whittington A; Wyatt P; Taylor N; Green D; Bethell R; Madar S; Fenton RJ; Morley PJ; Pateman T; Beresford A
J Med Chem; 1998 Mar; 41(6):787-97. PubMed ID: 9526555
[TBL] [Abstract][Full Text] [Related]
6. Syntheses and neuraminidase inhibitory activity of multisubstituted cyclopentane amide derivatives.
Chand P; Babu YS; Bantia S; Rowland S; Dehghani A; Kotian PL; Hutchison TL; Ali S; Brouillette W; El-Kattan Y; Lin TH
J Med Chem; 2004 Apr; 47(8):1919-29. PubMed ID: 15055992
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.
Smee DF; Sidwell RW; Morrison AC; Bailey KW; Baum EZ; Ly L; Wagaman PC
Antiviral Res; 2001 Dec; 52(3):251-9. PubMed ID: 11675142
[TBL] [Abstract][Full Text] [Related]
8. Carbocyclic influenza neuraminidase inhibitors possessing a C3-cyclic amine side chain: synthesis and inhibitory activity.
Lew W; Wu H; Chen X; Graves BJ; Escarpe PA; MacArthur HL; Mendel DB; Kim CU
Bioorg Med Chem Lett; 2000 Jun; 10(11):1257-60. PubMed ID: 10866394
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
Bantia S; Parker CD; Ananth SL; Horn LL; Andries K; Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin T; Hutchison TL; Montgomery JA; Kellog DL; Babu YS
Antimicrob Agents Chemother; 2001 Apr; 45(4):1162-7. PubMed ID: 11257030
[TBL] [Abstract][Full Text] [Related]
10. [Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].
Reina J
Rev Esp Quimioter; 2006 Dec; 19(4):317-22. PubMed ID: 17235399
[No Abstract] [Full Text] [Related]
11. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.
Kim CU; Lew W; Williams MA; Wu H; Zhang L; Chen X; Escarpe PA; Mendel DB; Laver WG; Stevens RC
J Med Chem; 1998 Jul; 41(14):2451-60. PubMed ID: 9651151
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of cyclopentane neuraminidase inhibitors protects ferrets against influenza virus infection.
Sweet C; Jakeman KJ; Bush K; Wagaman PC; McKown LA; Streeter AJ; Desai-Krieger D; Chand P; Babu YS
Antimicrob Agents Chemother; 2002 Apr; 46(4):996-1004. PubMed ID: 11897581
[TBL] [Abstract][Full Text] [Related]
14. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
Sidwell RW; Smee DF; Huffman JH; Barnard DL; Bailey KW; Morrey JD; Babu YS
Antimicrob Agents Chemother; 2001 Mar; 45(3):749-57. PubMed ID: 11181355
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
[TBL] [Abstract][Full Text] [Related]
16. Zanamivir. A potent and selective inhibitor of influenza A and B viruses.
Aoki FY; Hayden FG
Clin Pharmacokinet; 1999; 36 Suppl 1():v-ix. PubMed ID: 10429834
[No Abstract] [Full Text] [Related]
17. Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides.
Wyatt PG; Coomber BA; Evans DN; Jack TI; Fulton HE; Wonacott AJ; Colman P; Varghese J
Bioorg Med Chem Lett; 2001 Mar; 11(5):669-73. PubMed ID: 11266166
[TBL] [Abstract][Full Text] [Related]
18. Structural studies of the resistance of influenza virus neuramindase to inhibitors.
Smith BJ; McKimm-Breshkin JL; McDonald M; Fernley RT; Varghese JN; Colman PM
J Med Chem; 2002 May; 45(11):2207-12. PubMed ID: 12014958
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-Guanidino-Neu5Ac2en (Zanamivir) modified in the glycerol side-chain.
Andrews DM; Cherry PC; Humber DC; Jones PS; Keeling SP; Martin PF; Shaw CD; Swanson S
Eur J Med Chem; 1999; 34(7-8):563-74. PubMed ID: 11278042
[TBL] [Abstract][Full Text] [Related]
20. Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice.
Sidwell RW; Smee DF; Bailey KW; Burger RA
Int Immunopharmacol; 2001 Jun; 1(6):1211-8. PubMed ID: 11407315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
